GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » ROA %

Tauns Laboratories (TSE:197A) ROA % : 24.26% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tauns Laboratories's annualized Net Income for the quarter that ended in Jun. 2024 was 円5,774 Mil. Tauns Laboratories's average Total Assets over the quarter that ended in Jun. 2024 was 円23,797 Mil. Therefore, Tauns Laboratories's annualized ROA % for the quarter that ended in Jun. 2024 was 24.26%.

The historical rank and industry rank for Tauns Laboratories's ROA % or its related term are showing as below:

TSE:197A' s ROA % Range Over the Past 10 Years
Min: 15.72   Med: 22.11   Max: 24.26
Current: 24.26

During the past 3 years, Tauns Laboratories's highest ROA % was 24.26%. The lowest was 15.72%. And the median was 22.11%.

TSE:197A's ROA % is ranked better than
98.62% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: -1.65 vs TSE:197A: 24.26

Tauns Laboratories ROA % Historical Data

The historical data trend for Tauns Laboratories's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories ROA % Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
ROA %
22.11 15.72 24.26

Tauns Laboratories Semi-Annual Data
Jun22 Jun23 Jun24
ROA % 22.11 15.72 24.26

Competitive Comparison of Tauns Laboratories's ROA %

For the Medical Instruments & Supplies subindustry, Tauns Laboratories's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tauns Laboratories's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's ROA % distribution charts can be found below:

* The bar in red indicates where Tauns Laboratories's ROA % falls into.



Tauns Laboratories ROA % Calculation

Tauns Laboratories's annualized ROA % for the fiscal year that ended in Jun. 2024 is calculated as:

ROA %=Net Income (A: Jun. 2024 )/( (Total Assets (A: Jun. 2023 )+Total Assets (A: Jun. 2024 ))/ count )
=5774.086/( (18332.162+29261.325)/ 2 )
=5774.086/23796.7435
=24.26 %

Tauns Laboratories's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=5774.086/( (18332.162+29261.325)/ 2 )
=5774.086/23796.7435
=24.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Tauns Laboratories  (TSE:197A) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=5774.086/23796.7435
=(Net Income / Revenue)*(Revenue / Total Assets)
=(5774.086 / 18434.863)*(18434.863 / 23796.7435)
=Net Margin %*Asset Turnover
=31.32 %*0.7747
=24.26 %

Note: The Net Income data used here is one times the annual (Jun. 2024) net income data. The Revenue data used here is one times the annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Tauns Laboratories ROA % Related Terms

Thank you for viewing the detailed overview of Tauns Laboratories's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tauns Laboratories Business Description

Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines